The consortium addresses several key challenges in the field of nanotechnology, including:
Technical barriers in integrating nanomaterials with biological systems. Scalability issues in manufacturing nano-bio products. Regulatory hurdles for the commercialization of nanotechnology-based healthcare solutions.